The fourth annual conference for Asian new drug development was held
   in Tokyo in April, 2010. Several issues about Asian development were
   discussed
   intensively from the sponsor’s and the regulatory reviewer’s point of
   view.

   For the fifth conference, the program committee has been joined by
   colleagues from East Asian countries – China, the Republic of Korea,
   Chinese Taipei, and Japan – who are actively involved in drug
   development in Asia. Nowadays, the practical organizations for Asian
   collaboration have
   been set up and several fruitful outcomes have been published. The
   more critical topics have been selected.

   Main topics are as follows:
   1) Oncology
   2) Pharmacogenomics
   3) Safety Reporting, Pharmacovigilance
   4) GCP Compliance and Inspection
   Several experts in drug development from China, the Republic of Korea,
   Chinese Taipei, and Japan will share their experiences and discuss how
   we
   can contribute to healthcare and the patients in Asia. We are also
   planning for opportunities for substantive discussion with Asian
   regulators including
   PMDA in order to develop new drugs which contribute to public health.

   Event Code:
   11302